Mesoblast Limited
MESO
$16.11
$0.090.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -102.14M | -102.75M | -103.35M | -95.65M | -87.96M |
| Total Depreciation and Amortization | 6.40M | 5.35M | 4.30M | 4.49M | 4.67M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.83M | 51.86M | 54.90M | 46.18M | 37.46M |
| Change in Net Operating Assets | -3.04M | -715.50K | 1.61M | -510.00K | -2.63M |
| Cash from Operations | -49.95M | -46.25M | -42.54M | -45.50M | -48.46M |
| Capital Expenditure | -680.00K | -431.50K | -183.00K | -227.00K | -271.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 800.00K | 800.50K | 801.00K | 487.50K | 174.00K |
| Cash from Investing | 120.00K | 369.00K | 618.00K | 260.50K | -97.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.77M | -12.36M | -14.96M | -14.24M | -13.52M |
| Issuance of Common Stock | 166.38M | 96.71M | 27.04M | 46.22M | 65.41M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.28M | -8.49M | -7.70M | -9.66M | -11.63M |
| Cash from Financing | 147.34M | 75.86M | 4.39M | 22.32M | 40.25M |
| Foreign Exchange rate Adjustments | 1.09M | -450.50K | -1.99M | -1.02M | -55.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.59M | 29.53M | -39.53M | -23.94M | -8.36M |